RxDoctor Payments Data

Connor Golden, PA

Physician Assistant · Dubuque, IANPI 1720679871

Payments from drug & device makers

$2,935in general payments, 2019–2025

Across 81 payments — averaging $36.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$2K
  • Novartis$286
  • Pfizer$212
  • Medtronic$86
  • Si-bone, Inc.$61
  • Biogen$55
  • plus $309 from 11 others

What the payments were for

  • Travel & lodging$1,47350%
  • Food & beverage$1,46250%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,935 in reported general payments places this provider in the 90th percentile of 1,140 physician assistant providers in Iowa.

See all physician assistant providers in Iowa

Medicare billing

Part B allowed, 2024
$142,447
Medicare patients
242
Services billed
18,076

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpidiolexCannabidiol (Cbd)24$212,651
Kesimpta PenOfatumumab23$193,276
BetaseronInterferon Beta-1b11$105,434
CopaxoneGlatiramer Acetate12$70,122
Carbidopa-LevodopaCarbidopa/Levodopa721$29,402
Glatiramer Acetate13$18,223
RytaryCarbidopa/Levodopa26$14,625
Lacosamide96$13,553
MyrbetriqMirabegron42$11,732
UbrelvyUbrogepant12$11,582
NayzilamMidazolam16$10,876
Carbidopa-Levodopa ErCarbidopa/Levodopa262$9,629
LamictalLamotrigine11$7,956
Gabapentin426$6,971
Tegretol XrCarbamazepine12$6,829

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$53$11,58212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,140 physician assistant providers in Iowa.

Other physician assistant in Dubuque

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →